Neuromuscular stimulation and mindfulness breathing for stroke recovery
Effect of Neuromuscular Stimulation and Mindfulness Exercise on Pulmonary, Physical Functions and Stress in Patients With Stroke
This study is testing if adding mindfulness breathing to neuromuscular stimulation can help stroke patients recover better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 65 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Dokki) |
| Trial ID | NCT06302946 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to evaluate the effects of neuromuscular stimulation combined with mindfulness breathing on stroke patients. A total of 60 participants will be randomly assigned to either an experimental group receiving both treatments or a control group receiving only neuromuscular stimulation. The experimental group will undergo 12 weeks of treatment, with three sessions per week, focusing on mindful breathing as a technique to enhance recovery. The study seeks to determine if the addition of mindfulness breathing can improve outcomes for stroke patients.
Who should consider this trial
Good fit: Ideal candidates are stroke patients aged 50 to 65 who are hemodynamically stable and have good cognitive function.
Not a fit: Patients with cognitive impairments, unstable cardiovascular conditions, or contraindications to neuromuscular stimulation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and rehabilitation outcomes for stroke patients.
How similar studies have performed: While the combination of neuromuscular stimulation and mindfulness breathing is innovative, similar studies have shown positive outcomes with neuromuscular stimulation alone.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The subject selection will be according to the following criteria: * All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021). * Age of patients will be ranged from 50 to 65years (males and females). * All patients will be hemodynamically stable. * Patients with good cognition that enables them to understand the requirements of the study. Exclusion Criteria: * • The potential participants will be excluded if they meet one of the following criteria: * Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness. * Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD. * Patients with cognitive and psychiatric disorders. * Patients with unstable cardiovascular conditions. * Patients with contraindications to neuro electrical stimulation as: * Cardiac pace maker. * Acute abdominal surgery.
Where this trial is running
Cairo, Dokki
- Faculty of Physical Therapy — Cairo, Dokki, Egypt (Recruiting)
Study contacts
- Principal investigator: marwa elsayed — Cairo University
- Study coordinator: marwa elsayed, PhD
- Email: marwa.elsaid@cu.edu.eg
- Phone: 0201156033818
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.